| 产品描述: | TRx 0237 (LMTX) mesylate is a second-generation tau protein aggregation inhibitor for the treatment of Alzheimer's disease (AD) and frontotemporal dementia. |
| 靶点: |
Tau aggregation;BetaAmyloid; MicrotubuleAssociated |
| 体外研究: |
TRx 0237 (LMTX™) is a second-generation tau protein aggregation inhibitor for the treatment of Alzheimer's disease (AD) and frontotemporal dementia. It is a purified forms of Methylene Blue, an old drug that predates the FDA and is being widely used in Africa for the treatment for malaria as well as for methemoglobinemia and other conditions[2]. An in vitro study showed the ability of TRx 0237 in disrupting PHFs(paired helical filaments) isolated from Alzheimer's Disease brain tissues at the concentration at 0.16 μM。 |
| 体内研究: |
TRx 0237 dose-dependently rescues the learning impairment and restores behavioral flexibility in a spatial problem-solving water-maze task in L1 (minimum effective dose: 9 mg MT/kg for TRx0237) and correctes motor learning in L66 (effective doses: 4 mg MT/kg). It reduces the number of tau-reactive neurons, particularly in the hippocampus and entorhinal cortex in L1 and in a more widespread manner in L66。 |
| 细胞实验: |
用 H2O 作为溶剂配制的母液,过滤除菌后,可以直接用培养基稀释到所需的工作液浓度。 用 DMSO 作为溶剂配制的母液,在稀释时要确保工作液中 DMSO 的终浓度尽量在 0.1% 以下,最高不要超过 0.5% ,并设置相应浓度的 DMSO 对照组。临用前将培养基和DMSO母液预热至37℃或以上温度后进行稀释。 |
| 动物实验: |
注意事项:对于正常小鼠或大鼠,建议 DMSO 的终浓度不要大于 10%;对于裸鼠或体弱小鼠或大鼠,建议 DMSO 的终浓度尽量不要超过 2%;对于正常小鼠,如果给药频率超过一天三次,建议 DMSO 的终浓度尽量不要超过 5%。 |
| 参考文献: |
1. LMTM. THERAPEUTICS overview. 2. Panza F, et al. Tau aggregation inhibitors: the future of Alzheimer's pharmacotherapy?. Expert Opin Pharmacother. 2016, 17(4):457-61. 3. Gui W, Xu S, Dang Z, et al. In Vitro and in Vivo Effect of Mapk Signal Transduction Pathway Inhibitors on Echinococcus multilocularis[J]. Journal of Parasitology. 2019 Feb;105(1):146-154. 4. Liu Z, Wang F, Tang M, et al. Amyloid β and tau are involved in sleep disorder in Alzheimer's disease by orexin A and adenosine A (1) receptor[J]. International journal of molecular medicine. 2019 Jan;43(1):435-442. |
| 溶解性: |
H2O:41.67mg/ml;DMSO:37.5mg/ml 请分装保存,避免反复冻融造成的产品失效。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。 |
| 保存条件: |
-20℃ |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.094 ml |
10.469 ml |
20.937 ml |
| 5 mM |
0.419 ml |
2.094 ml |
4.187 ml |
| 10 mM |
0.209 ml |
1.047 ml |
2.094 ml |
| 50 mM |
0.042 ml |
0.209 ml |
0.419 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |